AIM
DGX icon

Artemis Investment Management’s Quest Diagnostics DGX Stock Holding History

Artemis Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2M Buy
467,921
+20,647
+5% +$4.05M 0.88% 40
2026
Q1 		$87.7M Sell
447,274
-13,451
-3% -$2.61M 0.93% 37
2025
Q4 		$79.9M Buy
460,725
+29,084
+7% +$5.3M 0.97% 32
2025
Q3 		$82.3M Buy
431,641
+208,193
+93% +$36.9M 1.02% 30
2025
Q2 		$40.1M Buy
+223,448
New +$38.8M 0.51% 72

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Artemis Investment Management's DGX Position: Q2 2026 in Review

Artemis Investment Management increased its Quest Diagnostics (DGX) stake by 4.6% in Q2 2026, buying an estimated $4.05M and bringing the position to 467,921 shares worth $99.2M. The position accounts for 0.88% of the portfolio, ranked #40.

Artemis Investment Management first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Artemis Investment Management held 467,921 shares of Quest Diagnostics worth $99.2M as of Q2 2026.
  • Artemis Investment Management bought 20,647 Quest Diagnostics shares in Q2 2026, an estimated $4.05M.
  • Quest Diagnostics made up 0.88% of Artemis Investment Management's portfolio in Q2 2026, its #40 holding.
  • Artemis Investment Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.